Not everyone struggling with weight can immediately start treatment with the Wegovy injection in Dubai. While this medication is highly effective in helping patients lose weight and improve metabolic health, it comes with specific eligibility criteria and medical requirements. Understanding who can safely use Wegovy—and under what conditions—is the first step toward a successful and safe treatment journey.
Who is Eligible for Wegovy?
Wegovy is generally recommended for adults who:
Have a BMI of 30 or higher (classified as obesity).
Have a BMI of 27 or higher with weight-related health issues, such as type 2 diabetes, hypertension, or high cholesterol.
Have tried lifestyle changes such as diet and exercise but struggled to achieve or maintain meaningful weight loss.
This makes Wegovy an option for both those with obesity and those at risk of obesity-related health conditions.
Age Requirements
Approved for adults aged 18 and older.
Not recommended for children or adolescents unless under exceptional circumstances and specialist supervision.
Key Medical Requirements Before Starting
Before prescribing Wegovy, healthcare providers in Dubai typically perform:
1. Medical History Review
Assessment of existing conditions (such as heart disease, diabetes, thyroid issues).
Review of family history to rule out risks like medullary thyroid carcinoma (a rare thyroid cancer).
2. Physical Examination
Measurement of weight, BMI, and waist circumference.
Vital checks, including blood pressure and heart health.
3. Blood Tests
To evaluate blood sugar, liver, and kidney function.
Helps identify underlying issues that may affect treatment safety.
4. Medication Review
Some medications may interact with Wegovy. Doctors ensure there are no conflicts that could impact effectiveness or safety.
Who Should Avoid Wegovy?
Wegovy is not suitable for certain patients, including those who:
Have a personal or family history of medullary thyroid carcinoma (MTC).
Have multiple endocrine neoplasia syndrome type 2 (MEN2).
Are pregnant or breastfeeding.
Have severe gastrointestinal issues (such as gastroparesis).
Have allergies to semaglutide or any ingredient in Wegovy.
Importance of Medical Supervision
Wegovy is not a self-prescribed treatment. In Dubai, it is strictly given under the guidance of licensed healthcare providers who monitor:
Dosage adjustments → Wegovy is started at a lower dose and gradually increased.
Side effect management → nausea, vomiting, or fatigue may occur initially.
Progress tracking → regular follow-ups ensure safe and effective results.
Realistic Expectations for Eligible Patients
Even if you qualify for Wegovy, it’s essential to understand that:
It is not a quick fix but a gradual weight management tool.
Results vary depending on adherence to lifestyle changes.
Long-term commitment is necessary for sustainable success.
Final Thoughts
The Wegovy injection in Dubai is a safe and effective treatment for weight loss—but only when patients meet eligibility criteria and medical requirements. Proper evaluation ensures that those starting the treatment benefit fully while minimizing risks.
For safe guidance, medical evaluation, and treatment planning, Tajmeels Clinic in Dubai provides expert care to determine patient eligibility and support individuals through every step of their Wegovy journey.
FAQs on Wegovy Eligibility
1. Can anyone take Wegovy in Dubai?
No, eligibility depends on BMI, health conditions, and doctor approval.
2. Is Wegovy suitable for people with diabetes?
Yes, especially for type 2 diabetes patients, but only under medical supervision.
3. Can pregnant women use Wegovy?
No, it is not safe during pregnancy or breastfeeding.
4. What tests are required before starting Wegovy?
Doctors may check blood sugar, liver, and kidney function, along with reviewing medical history.
5. Can people under 18 use Wegovy?
It is only approved for adults, except in rare cases with specialist approval.
